Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2013 Nov 12;50:137–142. doi: 10.1016/j.pnpbp.2013.11.001

Table 1.

Demographic and drug use characteristics.

Participant characteristics Placebo (N = 16) Riv 3 mg (N = 13) Riv 6 mg (N = 12)
Demographics
 Females (%) 12.5 23.1 16.7
 Caucasian (%) 0 7.7 16.7
 African–American (%) 68.8 69.2 75.0
 Hispanic (%) 12.5 23.1 8.3
 Mixed 18.8 0 0
 Age (years) 40.4 ± 2.0 43.9 ± 1.6 43.5 ± 1.6
 Education (years) 12.1 ± 0.3 12.7 ± 0.5 13.3 ± 0.6
Estimated premorbid IQ 96.5 ± 3.8 98.8 ± 3.4 102.9 ± 3.0
Cocaine use
 Route of use-smoke (%) 100 100 91.7
 Use in last 30 (days) 16.2 ± 1.9 18.6 ± 1.6 18.7 ± 2.7
 Use lifetime (years) 15.6 ± 1.8 15.8 ± 2.4 15.8 ± 2.3
 Grams per day 1.7 ± 0.3 2.9 ± 1.0 2.1 ± 0.4
Nicotine use N = 14 N = 11 N = 10
Use in last 30 (days) 22.2 ± 2.6 21.2 ± 2.0 30.0 ± 0.0
Use lifetime (years) 17.4 ± 2.1 19.8 ± 2.2 21.8 ± 3.2
Cigarettes per day 9.3 ± 1.7 7.9 ± 1.6 14.3 ± 1.7*
Alcohol use N = 15 N = 9 N = 10
Use in last 30 (days) 9.5 ± 2.1 10.8 ± 2.3 11.3 ± 3.0
Use lifetime (years) 19.1 ± 2.2 23.8 ± 0.8 19.1 ± 2.6
Drinks per day 3.1 ± 0.6 2.8 ± 0.4 2.4 ± 0.4

Values represent Mean ± SEM.

Number represents current users only.

Number represents days used in the part 30.

Number represents total number of years substance was used.